|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Thalidomide in multiple myeloma显示文摘 | Moehler TM Hillengass J Glasmacher A | 2006 | Curr Pharm Biotechnol2006，7，6： | 1 |
| 2 | Prognostic significance of focal lesions in whole-body magnetic resonance imaging in patients with asymptomatic multiple myeloma显示文摘 | Hillengass J Fechtner K Weber MA | 2010 | J Clin Oncol2010，28，： | 1 |
| 3 | Kyphoplasty in pa-tients with multiple myeloma a retrospective comparative pi-lot study 显示文摘 | Kasperk C Haas A Hillengass J | 2012 | J Surg Oncol2012，105，7： | 1 |
| 4 | Prognostic significance of focal lesions in whole-body magnetic res- onance imaging in patients with asymptomatic multiple myeloma 显示文摘 | Hillengass J Fechtner K Weber MA | 2010 | J Clin Onco12010，28，9： | 1 |
| 5 | Antiangio- genic therapy in hematologic malignancies显示文摘 | Moehler T M Hillengass J Goldschmidt H | 2004 | Curr Pharm Des2004，10，11： | 1 |
| 6 | Diffusion-weighted imaging for non-invasive and quantitative monitoring of bone marrow infiltration in patients with monoclonal plasma cell disease:a comparative study with histology显示文摘 | Hillengass J Bauerle T Bartl R | 2011 | Br J Haematol2011，153，6： | 1 |
| 7 | Kyphoplasty in pa- tients with multiple myeloma a retrospective comparative pilot study显示文摘 | Kasperk C Haas A Hillengass J | 2011 | J Surg Oncol2011，29，10： | 1 |
| 8 | Thalidomide versus dexamethasone for the treatment of relapsed and/or refractory multiple myeloma:results from OPTIMUM,a randomized trial显示文摘 | Kropff M Baylon HG Hillengass J | 2012 | Haematologica2012，97，5： | 1 |
| 9 | The role of positron emission tomography-computed tomography and magnetic resonance imaging in diagnosis and follow up ofmultiple myeloma显示文摘 | Caers J Withofs N Hillengass J | 2014 | Haematologica2014，99，4： | 1 |
| 10 | Challenges and opportunities of novel imaging techniques in monoclonal plasma cell disorders: imaging 'early myeloma'显示文摘 | Hillengass J Landgren O | 2013 | Leuk Lymphoma2013，54，： | 1 |
| 11 | Antiangiogenic therapy in hematologic malignancies 显示文摘 | Moehler TM Hillengass J Goldschmidt H | 2004 | Curt Pharm Res2004，10，11： | 1 |
| 12 | Thalidomide versus dexamethasone for the treatment of relapsed and/or refractory multiple myeloma:results from OPTIMUM,a randomized trial显示文摘 | Kropff M Baylon HG Hillengass J | | 0，，05： | 1 |
| 13 | Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement 显示文摘 | Dimopoulos MA Hillengass J Usmani S | 2015 | J Clin Oncol2015，33，6： | 1 |
| 14 | Quantitative assessment of microcirculation and diffusion in the bone marrow of osteoporotic rats using VCT, DCE-MRI, DW-MR!, and histology显示文摘 | Liu Y Cao L Hillengass J | 2013 | Acta Radiol2013，54，： | 1 |
| 15 | Quantitative Assessment of Micro- circulation and Diffusion in the Bone Marrow of Osteoporotic Rats U- sing Vct, Dee-Mri, Dw-Mri, and Histology显示文摘 | Liu Y Cao L Hillengass J | 2013 | Acta Radiol2013，54，： | 1 |
| 16 | Diffusion-weighted imaging for non-invasive and quantitative monitoring of bone marrow infiltration in patients with monoclonal plasma cell disease:a comparative study with histology显示文摘 | Hillengass J Buerle T Bartl R | 2011 | Br J Haematol2011，153，6： | 1 |
| 17 | Prognostic significance of focal lesions in whole-body magnetic resonance imaging in patients with asymptomatic multiple myeloma显示文摘 | HILLENGASS J K FECHTNER K WEBER M A | 2010 | J Clin Oncol2010，28，9： | 1 |
| 18 | Thalidomide versus dexamethasone for the treatment of relapsed and/or refractory multiple myeloma: results from OPTIMUM, a randomized trial 显示文摘 | Kropff M Baylon HG Hillengass J | 2012 | Haematologica2012，97，5： | 1 |
| 19 | Thalidomide versus dexamethasone for the treatment of relapsed and/or refractory multiple myeloma: results from OPTIMUM,a randomized trial显示文摘 | Kropff M Baylon HG Hillengass J | 2012 | Haematologica2012，97，5： | 1 |
| 20 | Quantitative assessment of microcirculation and diffusion in the bone marrow of osteoporotic rats using VCT, DCE -MRI,DW-MRI,and histology显示文摘 | Liu Y Cao L Hillengass J et a/ | 2013 | Acta Radiol2013，54，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员